Buy Cybergy Holdings

In: Tips

19 May 2015

Hi Everybody,

Our alert for Monday is:
Cybergy Holdings, Inc.
Ticker symbol: CYBG
Last price: $1.32

Fast Facts
• This company has approximately 100 employees in 3 divisions
• 2014 revenue $32 million
• They plan on uplisting to Nasdaq which requires a $4 stock price.

Cybergy Holdings, Inc. provides cyber security, smart grid technologies and renewable energy solutions to both government and private industry clients.

Why investors will be excited about CYBG…

1. CYBG posts 140% increase in contracts between 2014 and 2013.
2. CYBG lands $500 million 10 year contract with U.S. Department of Health and
Human Services.
3. CYBG will serve as a key partner to Allegheny Science & Technology Corp. (AST) on an $85 million 3 year contract.
4. CYBG labs expects to release its cyber security platform SmartFile in 2015.

Make sure you’re ready to book your profits with CYBG!

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading

Buy GrowBLOX Sciences

In: Tips

13 May 2015

Hi Everybody,

Our alert for Wednesday is:

GrowBLOX Sciences, Inc.
Ticker symbol: GBLX
Last price: $0.37

GrowBLOX Sciences, Inc. GBLX is a biopharmaceutical research and development company.

GBLX produces a technology called the “GrowBLOX”. The GrowBLOX is a new technology for marijuana growers.

GBLX’s GrowBLOX enables each plant to produce from 1 to 1½ pounds of marijuana every eight to twelve weeks.

No other product on the market is capable of achieving such an abundant yield per plant indoors.

GrowBLOX™ chambers are illuminated using energy-efficient LED lights and supplemented with magnetic induction lights for optimal growth at the lowest cost.

GBLX’s integrated, intelligent control system continuously monitors, manages, records, and analyzes the operation for optimal growth.

Remote-access capabilities let growers make real-time adjustments while they are on-the-go from their smartphone or computer.

GrowBLOX’s™ AeroVAPOR™ misting system delivers all of the moisture, nutrients, and oxygen that cannabis plants need to grow fast.

All of these features makes GBLX’s product a potentially huge seller in the marijuana marketplace…a marketplace that is growing larger by the day. Due to it’s ability to produce more with less, the company could find itself as the new standard bearer in grow technology, which could lead to some major revenues for this company.

Make sure you’re ready to book your profits with GBLX!

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading

Buy Axxess Pharma

In: Tips

6 May 2015

Hi Everybody,

Our alert for Wednesday’s business has quite a few things going for it:
• Aggressive marketing
• Strong consumer goods distribution
• Expanded global sales into Asia
• Presentations of their product line at the nation’s largest fitness expo
• Purchase orders from Australian distributors
• Promotions on a nationally live sporting syndicate

Our alert for Wednesday is:

Axxess Pharma, Inc.
Ticker symbol: AXXE
Last price: $0.078

AXXE is a specialty pharmaceutical and nutritional supplements company.

AXXE is one of those companies that you read about that graduate from the OTC and make the leap into NASDAQ or another big board exchange.

Less than a week ago AXXE announced that they have been approved by Canada’s leading health product franchise “Nutrition House” to sell its full line of Tapout products. The Tapout products will be available in over 60 high profile shopping centers across Canada by early summer.

With so much positive news and proof of their recent success, we won’t overload you in this report with all of them, but we encourage you take a look at their constant awesome news. Just head over to your quotation system of choice and take a look at the litany of positive announcements this company’s been making.

Life sciences sector growth correlates highly with countries’ general economic strength and health care spending levels. In 2013, global health care spending increased around 2.8 percent after decreasing in 2012; the Economist Intelligence Unit (EIU) expects that growth to accelerate by an annual average of 5.2 percent in 2014-2018 as the global economy continues to recover from recession.

AXXE looks like it’s at the bottom of a channel, meaning shares bought here could result in some easy profits rather quickly.

Make sure you’re ready to book your profits with AXXE.

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading

Buy Flasr

In: Tips

5 May 2015

Hi Everybody,

Acting on big news before the rest of the market has a chance to jump on is a sure fire way to make big bucks in the stock market.

So with that in mind, we have a money making idea everyone should take a look at.

This company just announced today their product will be rolling out to 400 stores next month and you are among the first to hear about it, so that puts you in the perfect position to get in early and make big money.

Our alert for Tuesday is:

Flasr, Inc.
Ticker symbol: FLSR
Last price: $0.12

FLSR is a tobacco accessory producer, targeting moist snuff users in the U.S.

FLSR’s unique product looks to serve this growing consumer base with their products.

While that may not sound so exciting, it is. Sales of smokeless tobacco products are on the rise and are expected to total about $7 billion in 2015 according to Morningstar.

FLSR’s first product, a 4-oz. pocket-size, portable tobacco flask, with unique bottle designs and revolutionary thumb-lok twist cap is starting to hit shelves.

Do you know anyone that chews tobacco? Have you ever seen them walking around with bottles of brown spit? Gross right? Well, FLSR’s flask will put an end to all that.

FLSR’s product will be available for the first time in 400 stores in the United States beginning June 2015.

That’s only a few weeks away! With product hitting the shelves soon, it won’t be long before we start getting headlines on sales.

Just like vaporizer and e-cig companies have been benefiting from the increased aversion amongst the public consciousness to cigarette smoking, the chewing tobacco market is taking off as well.

At this low price, with the massive national rollout and increased awareness, FLSR provides traders with a nice profit opportunity.

Make sure you’re ready to book your profits with FLSR.

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading

Buy Cybergy Holdings

In: Tips

20 Apr 2015

Hi Everybody,

Our alert for Monday is:
Cybergy Holdings Inc.
Ticker symbol: CYBG
Last price: $1.79

Cybergy Holdings Inc. provides cyber security, smart grid technologies and renewable energy solutions to both government and private industry clients.

CYBG Fast Facts
• Headquartered in Englewood, Colorado
• Approximately 100 employees
• 3 divisions
• 2014 revenue $32 million

5 reasons investors are excited about CYBG
1. CYBG posts 140% increase in contracts between 2013 and 2014.
2. CYBG lands $500 million 10 year contract with U.S. Department of Health and Human Services.
3. CYBG will serve as a key partner to Allegheny Science & Technology Corp. (AST) on an $85 million 3 year contract.
4. CYBG Labs expects to release its cyber security platform SmartFile in 2015.
5. CYBG announced it plans to uplist to NASDAQ. (Nasdaq requires a $4 price to qualify)

Make sure you’re ready to book your profits with CYBG!

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading

Hi Everybody,

Winners are popping up left and right, so we found an opportunity that could bring you some profits on Thursday morning!

It’s a stock we’ve covered before that has made traders big money, and looks set to do just that again.

The exciting thing is, there was just a mini-documentary shot at their $20 million tea operation in South Africa.

This is huge because OTC investors are generally skeptical on the operations of these companies, so this video should quell the concerns many investors normally have and could attract some big long term holders, which is great for the stock price!

Our alert for Thursday is:

Plandai Biotechnology

Ticker symbol: PLPL
Last price: $ 0.23

PLPL and its operations at the Senteeko tea estate in South Africa are the subject of a newly released video.

Watch the video here:

In the documentary, viewers get a look inside the gates of the Senteeko tea estate and see for themselves the beauty that makes up the property’s 8,000 acres. The video also highlights the many fields of tea that produce the raw material that Plandaí uses to make its highly bioavailable green tea extract, Phytofare® Catechin Complex.

PLPL’s video also visits North West University’s Potchefstroom Campus and learn first-hand, from the scientists there who put the company’s green tea extract through human clinical trials, just what bioavailability is and why getting the product into the bloodstream and keeping it there is so important to end users of Plandaí’s product or of any nutraceutical product for that matter.

The Head of the University’s Preclinical Drug Development Platform, Prof. Anne Grobler, explains PLPL’s incredible clinical trial results, and we learn more about the Pheroid technology that the company will employ to deliver its extracts deeper into the body on the cellular level.

While at Senteeko viewers get to see the company’s 30,000 square foot production facility and watch the staff at the factory turn tea leaves into a vibrant, rich emerald green colored green tea extract. In the video, both the company’s CEO and the V.P. of Sales and Marketing discuss Senteeko’s early days, the tea estate today, the production process, Plandaí’s sales and marketing efforts and its future plans with other extracts.

This video gives investors and traders a front row seat to see the potential in PLPL.

Make sure you’re ready to book your profits with PLPL!

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading

Buy SPYR

In: Tips

9 Apr 2015

Hi Everybody,

We’ve been having a great week so far. Today’s alert may be the best one yet!

This company is starting to hit some major radars. It’s seeing a lot of interest because of its potential in the fast growing digital advertising and mobile applications market.

The company also has over $6 million in the bank so it’s poised for expansion.

Our alert for Thursday is:
SPYR, Inc.
Ticker symbol: SPYR
Last price: $0.65

SPYR is a holding company, that through its wholly-owned subsidiary, Franklin Networks, is engaged in digital publishing and advertising operations.

SPYR currently owns and operates nine websites focused on topics including, food, travel, fitness, nutrition, fashion and parenting.

By creating valuable and sharable content on these sites, SPYR will be able to leverage the traffic and synergies between the sites to offer advertisers package deals on secondary markets.

In case you haven’t noticed this whole “internet advertising” thing is kind of a big deal.

Online ad sales continue to register double-digit percentage growth year over year. In 2013, online ad sales rose 17 percent to $42.8 billion up from $26 billion in 2010 and only $9.6 billion in 2004. In the U.S., the total digital advertising spend alone will rise to more than $52 billion in 2015 and will climb to more than $61 billion by 2017. It is numbers like this that explain why the transition by SPYR into the digital publishing space makes a whole lot of sense.

Oh, and they’ve also entered into the mobile app space with the creation of SPYR APPS LLC.?

The timing is perfect to enter the multi-billion dollar apps and games industry. A recent article highlighting the apps industry found that by 2017, it’s expected that over 268 billion app downloads will generate $77 billion worth of revenue. The article points out that in 2015 alone, 1 billion smartphones will be purchased. The popularity of the smartphone isn’t slowing down, and with it the popularity of downloading apps is growing exponentially.

With numbers like that it’s clear to see why even the digital games industry has gone mobile. The mobile apps industry is expected to grow 16.5 percent in 2015 with gaming apps accounting for over 30 percent of the U.S. mobile content market in 2015.

Not to mention that the company is cash positive, with over $6 million in the bank! Meaning they already have capital in place which is more than most OTC companies can say.

With all this going on it’s not hard to see why investors are flocking to SPYR.

Make sure you’re ready to book your profits with SPYR!

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading

Buy FONU2

In: Tips

8 Apr 2015

Hi Everybody,

Hope you had a good day yesterday, our drone call ran up 33% at one point.

Congratulations to everyone who booked profits!

So let’s keep it moving, to a penny with some big names involved, and looking like a major breakout is brewing.

Our alert for Wednesday is:

FONU2, Inc.
Ticker symbol: FONU
Last price: $0.09

FONU is a film studio, production and social commerce company actively developing a 1,560 acre film studio complex, “Studioplex” in Effingham County, Georgia.

Why Georgia?
• Georgia is #1 in growth nationwide for film in production ahead of both California and New York.
• Demand in Georgia far outweighs supply.
• Georgia currently has an inventory shortage estimated at over 20 soundstages to accommodate the entertainment business needs.
• Record government support including grants, rebates and tax incentives enhances profitability.
• In 2014 alone, Georgia feature films and television productions generated an economic impact of $5.1 billion.
• Qualifying productions receive up to a 30% tax credit.

Hollywood Elite Onboard
In addition to building the Studioplex, the company has also acquired the worldwide distribution rights to Nick Cassavete’s Yellow. Cassavete’s wrote and directed Yellow. He has also directed and wrote for many other notable films such as The Other Woman, The Notebook, John Q, and Blow to name a few.

FONU is also producing a film being directed by the legendary Penny Marshall, who directed According to Jim, A League of Their Own, Big,Jumpin’ Jack Flash, and Laverne & Shirley.

The Hollywood experience doesn’t end there as FONU recently appointed new COO Alice P. Neuhauser whose resume includes financing some of the largest independently financed pictures including Terminator 2, Cliffhanger, Basic Instinct and Total Recall.

Investment Highlights
• Largest studio project in America.
• Cost savings versus competing studios.
• Management team track record includes both the successful creation and construction of a leading production studio as well as producing over 200 movies, which have generated in excess of $3 billion in box office receipts.

FONU looks like it could have a huge week heading into their presentation at the Growth Capital Expo next week. With that in mind traders are snatching up shares, and this could be a major winner for anyone involved.

Make sure you’re ready to book your profits with FONU!

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading

Hi Everybody,

Commercial drones are hot!

Drones are poised to have a huge impact on the US economy, according to the world’s largest unmanned systems industry organization.  The report released by the Association for Unmanned Vehicle Systems International (AUVSI) forecasts the total domestic impact to reach more than $82 billion.

Recently, a commercial drone stock VMRI, ran almost 200% from 2 bucks to almost 6 dollars!

So when we saw this news after market we knew we had to scramble and get a report to you ASAP!

The company we’re alerting you to, just released news after the bell that they acquired 100% of the licensing rights for manufacturing and distribution of North American Drones Enterprise Inc.’s (NAD) branded line of drone product!

Our alert for Tuesday is:
Golden Star Enterprises, Ltd.
Ticker symbol: GSPT
Last price: $0.09

NAD is in the business of producing and marketing drones to a wide range of potential users for commercial and recreational use.  Drones, most commonly associated with military applications are increasingly developing civil applications.

Drone services include aerial surveying, aerial video and photography, search and rescue operations, inspecting power lines and pipelines, counting wildlife, delivery of supplies (particularly to remote areas), forest fire detection, surveillance, and much more.  A large number of tasks performed from the ground today that are either personnel intensive, infrastructure intensive, or time intensive, can be more easily accomplished through the use of drones.

GSPT’s focus is to sell drones that make it easy for the everyday consumer to use and allow businesses to provide services new to their industry.  The core business can be divided into two main areas:
1. The highly customized sales of drones in the “Mini”, the “Prosumer” and “commercial use” market segments; and,
2. The leasing of purpose built drones to assist the private sector in specific lines of work.

GSPT currently has three different drones in their brand and they are, The X Factor (18.5×18.5x2cm), Kasper (35x35x10cm) and I-Sky (80x40x42cm).  What differentiates NAD from its competitors is that its drones are sold at a lower price point, and its drones can be operated by novices and experts alike.

GSPT through NAD has an exclusive co-branding, distribution agreement in place with one of the top drone makers in the world (manufacturer of “Ghost” drones) to sell co-branded drones throughout North America.

As we said, the drone market is going to be huge and investors are taking a bite at every opportunity they have to get into this market.  GSPT may be the best option yet, and at this price point could bring investors back value very quickly.

Make sure you’re ready to book your profits with GSPT!

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading

Buy PharmaCyte Biotech

In: Tips

25 Mar 2015

Hi Everybody,

Everyday there’s a new biotech running, creating profit opportunities for savvy traders.

With this in mind we found a nice looking biotech, that has received FDA orphan drug designation for their pancreatic cancer treatment. They are in phase 2b of clinical trials which are expected to commence this year.

That’s not all, this pancreatic treatment is based on the company’s cellulose-based live cell encapsulation technology known as Cell-in-a-Box(R) which may also be useful in treatment for other forms of cancer as well as diabetes.

The fact is this company has a real shot at making some waves as larger investors are more willing to take chances on little known biotechs due to the current market condition.

Our alert for Wednesday is:
PharmaCyte Biotech, Inc.
Ticker symbol: PMCB
Last price: $0.10

PMCB is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box(R).

PMCB’s patented Cell-in-a-Box treatment, has earned FDA ‘orphan drug designation’, for the treatment of pancreatic cancer. They will be executing Phase 2b of their clinical trials vs. a treatment using Eli Lilly’s Gemzar and Celgene’s Abraxane®.

Celgene is a billion dollar market cap company, and Eli Lilly is even bigger…if PMCB’s trials are successful this could end up as a wild ride for early investors.

But even before any of that happens, the sheer potential of this story as it makes its rounds could make for some major price swings.

The smallcap biotech sector is leading the market, and PMCB is a beautiful opportunity at capitalizing on this trend.

Make sure you’re ready to book your profits with PMCB!

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading


Categories

Thanks to our sponsors